Depomed, Inc.has announced that it has entered into a definitive agreement to acquire the U.S. rights to the Nucynta franchise...
Depomed, Inc. announced that it has closed the acquisition of the U.S. rights to the Nucynta franchise from Janssen Pharmaceuticals,...
A Phase III study suggests Nucynta ER (tapentadol) tablets, from J&J Janssen, were significantly more effective than placebo in providing...